20/20 Biolabs, Inc. Stock: price and insider trades · United States

20/20 Biolabs, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). The last twelve months, up to 18 October 2026, brought 4 filings signed by 4 insiders.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

With 4 filings in twelve months, the company is quieter than the median of 19 filings across the 5,811 companies we follow on the same exchange.

Insider buying of 20/20 Biolabs, Inc. has been absent for the past year. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade.

In the same market, recent insider purchases at GameStop Corp. and Heico Corp also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.